Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
84 Cards in this Set
- Front
- Back
Sedatives, formerly known as __________, produce calmness and relaxation and are therefore AKA ___________.
|
1. minor tranquilizers
2. anxiolytic (antianxiety agents) |
|
sedatives are not intended for ___________, as this use contributes to the abuse potential
|
stress and tension of everyday living
|
|
a sedative produces _______, while a hypnotic produces ___________, and all hypnotics are __________
|
1. calmness and relaxation
2. sleep 3. sedatives |
|
Describe the stages of sleep:
1. Stage 0 2. Stage 1 3. Stage 2 4. REM sleep |
1. awake
2. onset of sleep 3. light, restful sleep that makes up 50% of total sleeptime 4. 25% of total sleep time |
|
with each sleep cycle, the ________ increases
|
amount of REM sleep
|
|
Do sedative-hypnotics tend to cause both physical and psychological dependence?
|
Yes (It can occur within 1-3 months)
|
|
Describe the dose-related effects of CNS depressants:
1. low doses 2. higher doses 3. highest doses |
1. sedative
2. hypnotic 3. anesthetic |
|
Are CNS depressants used to treat anxiety and/or insomnia?
|
No
|
|
CNS agents have a _______therapeutic index and exhibit ____________ activity
|
1. narrow
2. anticonvulsant |
|
Barbituates are __________, which causes numerous drug interactions
|
inducers of the P450 system
|
|
ADR of barbituate sedative-hypnotics:
1. large doses lead to_______ 2. chronic use leads to _______ 3. barbituate abstinence syndrome? |
1. prolonged CNS depression
2. tolerance, dependence, and withdrawal 3. life threatening condition involving convulsions and delirium |
|
what are two components of barbituate tolerance?
|
-enzyme induction and CNS changes
|
|
how does overdose of barbituates lead to fatality?
|
depression of medullaryrespiratory and CV control centers leads to respiratory failure
|
|
barbituates have additive/synergistic CNS depression when used with __________
|
other depressants such as alcohol
|
|
indications for benzodiazepines?
|
insomnia (characterized by difficulty falling asleep, frequent nocturnal waking or early morning waking)
|
|
name three benzodiazepines used for insomnia?
|
Estrazolam, Triazolam, Flurazepam
|
|
benzodiazepines potentiate neuronal transmission involving pathways using _______ as an inhibitory neurotransmitter
|
GABA
|
|
There are two subtypes of the GABA-A receptor. Stimulation of which receptor results in sleep onset and cycle regulation?
|
-BZ1
|
|
which GABA-A receptor types are activated by benzodiazepines?
|
-all are activated nonspecifically, which accounts for the wide range of actions of benzodiazepines
|
|
1. which three agents can only activate one BZ binding site?
2. what does this binding account for? |
1. Zolpidem, Zalepon, and Eszopiclone
2. relatively selective hypnotic action and lack of anticonvulsant and muscle relaxant effects |
|
Both barbituates and benzodiazepines have additive/synergistic effects with other CNS depressants, which has more CNS depressant activity?
|
barbituates
|
|
Give three reasons why barbituates are more likely to be CNS depressants
|
1. they bind to specific receptors that are different from BZ receptors
2. Direct GABAmimetic activity at higher concentrations 3. Inhibition of excitatory CNS neurotransmitters |
|
How do BZs affect sleep patterns?
|
-decrease stages 0 and 1 and the # of wakenings
-increase stage 2 and REM sleep -onset of REM is delayed and dreaming is diminished |
|
how soon does tolerance develop to benzos?
|
several weeks
|
|
which type of benzos are best at achieving rapid onset, duration through the night, and no residual hangover?
|
short-acting and medium-acting
|
|
__________is a short-acting benzo that is associated with rebound insomnia and early morning awakening
|
Triazolam
|
|
name two intermediate acting benzos?
|
estazolam and temazepam
|
|
_____________is a long-acting benzo agent with an active metabolite that has a long half-life
|
Flurazepam
|
|
which benzo agent has increased daytime anxiety after ten days of continuous use due to tolerance and "interdose withdrawal"?
|
triazolam
|
|
name an ADR of triazolam that is considered to be a class effect of benzos
|
anterograde amnesia
|
|
describe the withdrawal symptoms related to physical dependence on benzos and the method of discontinuance
|
-muscle cramps, tremors, convulsion
-gradual withdrawal with a tapering schedule lasting > 2wks |
|
which nonbarbiturate, nonbenzo sedative-hypnotic agents are approved for short-term tx of insomnia? (2)
|
-zolpidem and zaleplon
|
|
which nonbarbiturate, nonbenzo sedative-hypnotic agents are approved for tx of insomnia? (3)
|
-zolpidem ER, eszopiclone, and ramelteon
|
|
chloral hydrate is rapidly absorbed and metabolized to its active metabolite, ___________
|
trichloroethanol
|
|
trichloroethanol,active metabolite of chloral hydrate, has what effects of sudden withdrawal/detoxification?
|
seizures, hallucinations, and delirium
|
|
describe the interaction between chloral hydrate with alcohol and CNS depressants
|
-additive/synergistic effects because they competitively inhibit each other's metabolism
|
|
zolpidem is a _______receptor agonist that preferentially interacts with __________receptor subtypes
|
1. benzodiazepine
2. BZ1 |
|
does the dose at which zolpidem exerts hypnotic effects cause anxiolytic, anticonvulsant, and muscle relaxant effects?
|
nope
|
|
how does zolpidem affect the sleep cycle?
|
-decreases sleep latency (stage 1)
-increases total sleep time and duration |
|
therapy with zolpidem should be limited to what time period?
|
7-10 days
|
|
which ADR appear to be minimal with Zolpidem?
|
tolerance, dependence, withdrawal, and rebound insomnia
|
|
__________is the first and only ER sleep med that promotes falling asleep and maintaining sleep with no significant decrease in next-day performance.
|
Zolpidem tartrate ER
|
|
indication for zolpidem tartrate ER
|
-tx of insomnia characterized by difficulties with sleep onset and/or sleep maintenance
-not limited to short-term tx |
|
MOA of Zaleplon
|
-BZ1 receptor agonist
-shortens time to sleep onset -DOES NOT increase sleep duration or reduce # of awakenings |
|
administration/dosing of zaleplon
|
-admin immediately at bedtime or up to 4 hr prior to anticipated wake time for difficulty falling asleep
-does not cause residual sedation and next-morning memory impairment when dosed in middle of the night |
|
what kind of agent is eszopliclone?
|
active S-isomer of the hypnotic zopiclone (a BZ1 receptor agonist)
|
|
characteristics of eszopiclone:
1. effects on insomnia 2. ADR 3. limited to short term use? |
1.improves all components of insomnia
2. less likely to cause ADR such as dependence, abuse potential, residual daytime psychomotor and memory impairment 3. no |
|
___________is a selective melatonin receptor agonist that stimulates type 1 (MT1).
|
ramelteon
|
|
indication for ramelteon
|
-adult insomnia characterized by difficulty with sleep onset
-not limited to short term use |
|
is ramelteon a controlled substance? Why or why not?
|
-no-it has no evidence of abuse potential ordependence
|
|
what are the pharmacological actions that benzodiazepine anxiolytics share?
|
-hypnotic, anxiolytic,anticonvulsant, muscle relaxant, amnesiac
|
|
what are the advantages of benzodiazepine anxiolytics?
|
-rapid onset, high therapeutic index, and relatively few ADR
|
|
what are the disadvantages of benzodiazepine anxiolytics
|
-tolerance, impaired psychomotor skills, dependence (so D/c gradually)
|
|
GAD::
1. 1st lline drugs 2. 2nd line drugs 3. when would you use benzos? |
1. antidepressants
2. buspirone 3. for acute relief or if symptoms warrant |
|
DOC of relieving stress-related anxiety related to major life stressful events
|
-benzos
-especially effective for insomnia and restlessness |
|
Panic D/O::
1. 1st line drug and time to improved symptoms? 2. 2nd line drug and which one is effective within days? |
1. SSRIs-2-3 wks
2, BZs-alprazolam |
|
PTSD DOC
|
SSRIs
|
|
Alcohol Withdrawal Syndrome::
1. symptoms within 1st 2 days? 2. within 1st 3 days? |
1. tonic-clonic seizures
2, delirium tremens-hyperthermia, tachycardia, delirium, and hallucinations |
|
AWS::
1. DOC 2. agents with fewer rebound effects and withdrawal seizures 3. agents that do not undergo hepatic metabolism, metabolized to inactive compounds, and short duration of action? 4. what dose for elderly or pts with hepatic dz? |
1. BZs
2. Chlordiazepoxide and Diazepam (longer-acting) 3. Lorazepam and Oxazepam(short-acting) 4. 50% pf dose used in younger pts |
|
indications for diazepam
|
-muscle relaxant, anticonvulsant, and preoperative medication
|
|
indications for lorazepam?
|
-preanestheic med to produce sedation and amnesia, status epilepticus
|
|
indications for alprazolam?
|
-panic D/O w/wo agoraphobia
|
|
indications for chlordiazepoxide?
|
acute alcohol withdrawal
|
|
MOA of BZs
|
-GABA-A rec is liandgated ion channel that when activated opens and allows chloride ion influx
-accumulation of chloride anions causes hyperpolarization of cell -decreases/interrupts synaptic and neuronal transmission |
|
GABA-A rec contains _________binding sites for BZs, therefore BZs act as ___________of GABA activity
|
1. three
2. allosteric modulators (frequency of Cl channel opening is increased adn GABA activity is enhanced but in absence of GABA they have no action) |
|
pharmacological actions of BZs produced by activation of GABA-A rec? (3)
|
-hypnotic, anticonvulsant, and muscle relaxant
|
|
what are the effects that occur at BZ doses beyond those needed for anxiolytic and amnesic effects?
|
ataxia and sedation
|
|
Therapeutic index of BZs
|
-wide (high)
|
|
IM admin of diazepam and clordiazepoxide is poorly absorbed due to ___________and peak levels are __________and ___________compared to oral dosing
|
1. poorly absorbed due to precipitation in muscle causing slow erratic absorption
2. lower 3. take longer to reach |
|
___________is a common active metabolite for several BZs, including diazepam and accumulation of this can occur with chronic dosing and cause___________
|
1. desmethyldiazepam
2. oversedation and ataxia |
|
withdrawal symptoms for BZs
|
-muscle cramps, tremor, tonic-clonic seizures
|
|
ADR for BZs
|
CNS depression (drowsiness, sedation, lethargy, impaired psychomotor performance)
|
|
results of overdose of BZs
|
-only mild respiratory suppresion, unless taken with alcohol which can be fatal
|
|
additive/synergistic effects of BZs and other CNS depressants can lead to ________
|
severe ataxia
|
|
only approved indication for buspirone?
|
-mgmt of anxiety d/o or short-term relief of anxiety
|
|
MOA of buspirone
|
-reduces serotonergic activity in states of serotonin excess
-partial agonist for serotonin postsynaptic receptors -antagonist in presence of 5HT -full agonist at 5HT1A presynaptic receptors(inhibits 5HT release) |
|
what is the significance of buspirone not binding to BZ receptors or affecting GABAergic transmission?
|
- no anticonvulsant or muscle relaxant effects
- lacks prominent sedative effects of other anxiolytics -does not exhibit cross-tolerance with BZs and other sedative/hypnotics |
|
optimal result with buspirone require tx for how long?
|
3-4wks
|
|
what can happen as a result for buspirone's affinity for DA receptors?
|
-potential to cause symptoms of dopamine blockade
|
|
DI of buspirone?
|
-MAOIs contraindicated
-P450 can cause buspirone to elevate up to 13x, causing drowsiness and dizziness |
|
effects of abrupt discontinuation of buspirone?
|
none
|
|
MOA of Flumazenil
|
-BZ receptor competitive antagonist
-does NOT reverse effects of ethanol, barbituates, opioids,or general anesthetics |
|
indications for flumazenil
|
-complete or partial reversal of sedative effects of BZs where::
-general anesthesia induced or maintained with BZs -sedation prod by BZs for diagnostic and therapeutic procedures -mgmt of BZs overdose is necessary (as adjunct to supportive measures) |
|
primary ADR of flumazenil
|
-risk of seizures due to reversal of BZ effects in high risk populations:
-concurrent sedative-hypnotic w/d -concurrent tricyclic antidepressant poisoning -physical dependence on BZs |